ACCRUED EXPENSES - Schedule (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Accrued Liabilities, Current [Abstract]
Accrued compensation	$ 2,274	$ 2,393
Accrued preclinical and clinical trial costs	1,124	756
Accrued interest	280	302
Accrued consulting	107	68
Accrued restructuring charges	0	3
Accrued other	123	116
Total accrued expenses	$ 3,908	$ 3,638